Clinical Trials Browser

Terminated × INDUSTRY × Ependymoma × Clear all

Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Neoplasms, Oligodendroglioma

NCT01032070 2024-12-12

PETEY

Phase 2 Terminated

25 enrolled 23 charts

Familial ependymoma, Ependymoma, Recurrence

NCT01247922 2024-12-06

Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205

Phase 2 Terminated

4 enrolled 9 charts

Familial ependymoma, Ependymoma

NCT04730349 2023-03-24

PIVOT IO 020

Phase 1/2 Terminated

15 enrolled 14 charts

CNSDermatologicLymphoidOther hematologic neoplasmSarcoma

Ependymoma, Glioma, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Medulloblastoma, Melanoma, Neoplasms, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Leukemia, B-Cell

NCT03967093 2021-07-22

KOURAGE

Phase 1 Terminated

9 enrolled

CNS

Brain Neoplasms, Ependymoma, Neoplasms

Clinical Trials

PEAR-GLIO

PETEY

Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205

PIVOT IO 020

KOURAGE